ATC code V03
| ATC code V: Various |
|---|
|
| Other ATC codes |
ATC code V03 All other therapeutic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup V03 is part of the anatomical group V Various.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV03.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
V03A All other therapeutic products
V03AB Antidotes
- V03AB01 Ipecacuanha
- V03AB02 Nalorphine
- V03AB03 Edetates
- V03AB04 Pralidoxime
- V03AB05 Prednisolone and promethazine
- V03AB06 Thiosulfate
- V03AB08 Sodium nitrite
- V03AB09 Dimercaprol
- V03AB13 Obidoxime
- V03AB14 Protamine
- V03AB15 Naloxone
- V03AB16 Ethanol
- V03AB17 Methylthioninium chloride
- V03AB18 Potassium permanganate
- V03AB19 Physostigmine
- V03AB20 Copper sulfate
- V03AB21 Potassium iodide
- V03AB22 Amyl nitrite
- V03AB23 Acetylcysteine
- V03AB24 Digitalis antitoxin
- V03AB25 Flumazenil
- V03AB26 Methionine
- V03AB27 4-dimethylaminophenol
- V03AB29 Cholinesterase
- V03AB31 Prussian blue
- V03AB32 Glutathione
- V03AB33 Hydroxocobalamin
- V03AB34 Fomepizole
- V03AB35 Sugammadex
- V03AB36 Phentolamine
- V03AB37 Idarucizumab
- V03AB38 Andexanet alfa
- V03AB54 Pralidoxime and atropine
- QV03AB90 Atipamezole
- QV03AB91 Sarmazenil
- QV03AB92 Diprenorfin
- QV03AB93 Yohimbine
- QV03AB94 Tolazoline
- QV03AB95 Apomorphine
- QV03AB96 Ropinirole
V03AC Iron chelating agents
- V03AC01 Deferoxamine
- V03AC02 Deferiprone
- V03AC03 Deferasirox
V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
- V03AE01 Polystyrene sulfonate
- V03AE02 Sevelamer
- V03AE03 Lanthanum carbonate
- V03AE04 Calcium acetate and magnesium carbonate
- V03AE05 Sucroferric oxyhydroxide
- V03AE06 Colestilan
- V03AE07 Calcium acetate
- V03AE08 Ferric citrate
- V03AE09 Patiromer calcium
- V03AE10 Sodium zirconium cyclosilicate
V03AF Detoxifying agents for antineoplastic treatment
- V03AF01 Mesna
- V03AF02 Dexrazoxane
- V03AF03 Calcium folinate
- V03AF04 Calcium levofolinate
- V03AF05 Amifostine
- V03AF06 Sodium folinate
- V03AF07 Rasburicase
- V03AF08 Palifermin
- V03AF09 Glucarpidase
- V03AF10 Sodium levofolinate
- V03AF11 Arginine and lysine
- V03AF12 Trilaciclib
V03AG Drugs for treatment of hypercalcemia
- V03AG01 Sodium cellulose phosphate
- V03AG05 Sodium phosphate
V03AH Drugs for treatment of hypoglycaemia
- V03AH01 Diazoxide
V03AK Tissue adhesives
V03AM Drugs for embolisation
V03AN Medical gases
- V03AN01 Oxygen
- V03AN02 Carbon dioxide
- V03AN03 Helium
- V03AN04 Nitrogen
- V03AN05 Medical air
V03AX Other therapeutic products
- V03AX02 Nalfurafine
- V03AX03 Cobicistat
- V03AX04 Difelikefalin
V03AZ Nerve depressants
- V03AZ01 Ethanol
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code V03". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QV03". WHO Collaborating Centre for Drug Statistics Methodology.